Bio-Rad Honored With Awards

(Hercules, CA, USA) has received a Market Leadership Award for drug discovery technologies for the company's KnowItAll ADME (absorption, digestion, metabolism, excretion)/Tox software and databases. The award, from the international consulting firm Frost & Sullivan (Palo Alto, CA, USA), is given to a single company annually that has displayed excellence in all areas of market leadership, including the identification of market challenges, drivers and restraints, as well as strategy development and methods of addressing these market dynamics.

"The company is recognized for excelling in market share, revenue growth rates, and profitability, as well as market and technology innovation,” explained Dr. Amarpreet Dhiman, industry analyst with Frost & Sullivan. "A clear understanding of end-user needs, a commitment to providing outstanding customer service, and the ability to forge productive collaborations have powered the constant expansion of the award recipient's client base.”

Bio-Rad's KnowItAll informatics system for in silico ADME/Tox offers a complete suite of tools for the computer-based prediction of a potential drug's ADME/Tox profile, including one of the largest collections of predictive models, applications to build and validate predictive models, experimental ADME/Tox data, and integrated tools for chemical structure handling, data management, and reporting.

Bio-Rad also received a Product Innovation Award from Frost & Sullivan for ADME/Tox Informatics. Winners are selected on the basis of market participant interviews, end-user surveys, and secondary research. The recipient must also demonstrate innovation by launching a broad line of emerging products and technologies.




Related Links:
Bio-Rad